Trusted Resource for Clinical Trials, Protocols & Progress
Risk-Based Approaches to CRO Data Oversight Implementing Risk-Based Strategies for CRO Data Oversight Introduction: The Shift Toward Risk-Based Oversight The complexity of modern clinical trials, coupled with outsourcing to multiple Contract Research Organizations (CROs), requires sponsors to adopt risk-based approaches for data oversight. Instead of reviewing every data point uniformly, regulators and sponsors now encourage…
Conducting QA Audits in Rare Disease Clinical Trials How to Effectively Conduct QA Audits in Rare Disease Clinical Trials The Importance of QA Audits in Orphan Drug Development Quality Assurance (QA) audits are vital in clinical research, serving as a proactive tool to ensure Good Clinical Practice (GCP) compliance, data integrity, and regulatory readiness. In…
Read More “Conducting QA Audits in Rare Disease Clinical Trials” »
How CROs Should Prepare for Sponsor Audits Preparing CROs Effectively for Sponsor Audits Introduction: Why Sponsor Audits Are Critical for CROs Sponsor audits are one of the most frequent external evaluations faced by Contract Research Organizations (CROs). Unlike regulatory inspections, which focus on statutory compliance, sponsor audits primarily assess whether the CRO is meeting contractual…
